<?xml version="1.0" encoding="UTF-8"?>
<p>Yellow fever (YF) is the most severe arbovirus to circulate in the Americas, with symptoms ranging from mild non-specific illness to hemorrhagic fever, a systemic illness characterized by high viremia, hepatic, renal and myocardial injury, hemorrhage, and high lethality [
 <xref rid="pntd.0007661.ref001" ref-type="bibr">1</xref>]. A single-dose vaccine has existed since the 1940s and has helped to substantially control and reduce YF transmission [
 <xref rid="pntd.0007661.ref002" ref-type="bibr">2</xref>â€“
 <xref rid="pntd.0007661.ref004" ref-type="bibr">4</xref>]. However, complete eradication is prevented by the sylvatic cycle of the virus within nonhuman primary hosts, and 
 <italic>Aedes aegypti</italic> mosquitoes are responsible for occasional transmission to people [
 <xref rid="pntd.0007661.ref005" ref-type="bibr">5</xref>]. Recent important outbreaks of YF in Africa and South America have confirmed the potential of arthropod-borne viruses to emerge or reemerge in risk areas [
 <xref rid="pntd.0007661.ref006" ref-type="bibr">6</xref>] and have highlighted the urgent need to assess vaccination coverage efforts in the most exposed countries.
</p>
